EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis

Fengle Jiang iD, Yuan Dang iD, Zheting Zhang, Yanan Yan, Yingchao Wang, Yi Chen, Lihong Chen, Jialiang Zhang, Jingfeng Liu iD, Jianmin Wang iD

mSystems · 21.01.2025 · 10 (1)

DOI: 10.1128/msystems.00765-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, erschienen am 21.01.2025. Verfasst von Fengle Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Microbiota. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science Research Program for Young and Middle-aged Health Professionals of Fujian Province, China, | Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation), Joint Fund for the Innovation of Science and Technology of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The evidence that intratumoral microbiomes, as a rising hallmark of cancer, have a profound impact on cancer phenotypes is increasingly compelling. However, the impact of the composition and diversity of the intratumoral microbiome on the prognosis of patients undergoing surgical resection for hepatocellular carcinoma (HCC) remains incompletely understood. In this study, we revealed a high abundance of bacteria in the neoplastic tissues. The presence of bacterial lipopolysaccharide and lipoteichoic acid was detected alongside tumor-associated immune cells. By utilizing 16S rRNA gene sequencing, we identified a specific intratumoral microbiome signature that was highly predictive of the prognosis for HCC patients who underwent surgical resection. Specifically, the presence of Intestinimonas, Brachybacterium, and Rothia were identified as independent risk factors for the overall survival of HCC patients who underwent surgical resection. IMPORTANCE Although some studies have shown an abundance of bacteria in hepatocellular carcinoma (HCC), there is still limited understanding of the composition and diversity of the intratumoral microbiome that is favorable or adverse to the prognosis of HCC patients. Our results indicated that a greater abundance of bacteria could be observed in the neoplastic tissues than in nonneoplastic tissues. Bacterial cell wall components largely coincided with tumor-associated immune cells. The bacteria in the long overall survival (LOS) group were associated with metabolism and cytokine‒cytokine receptor interaction pathways, while bacteria in the short overall survival (SOS) group were associated with proinflammatory and cell proliferation pathways. Notably, specific taxa could independently predict HCC prognosis. Based on these findings, intratumoral microbiomes facilitate the use of precision medicine in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicrobiotaHumansPrognosisFemaleMaleMiddle AgedRNA, Ribosomal, 16SBacteriaAgedTeichoic AcidsLipopolysaccharides

Stichwörter der Autor:innen

16S rRNA gene sequencingbacterial componentshepatocellular carcinomaintratumoral microbiometumor-associated immune cells

Substanzen

RNA, Ribosomal, 16Slipoteichoic acidTeichoic AcidsLipopolysaccharides

Autor:innen und Institutionen

  • Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China.
  • The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
  • Department of Hepatopancreatobiliary Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

ORCID-Profile: Fengle Jiang, Yuan Dang, Jingfeng Liu, Jianmin Wang

Förderung

  • Major Science Research Program for Young and Middle-aged Health Professionals of Fujian Province, China
  • | Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation)
  • Joint Fund for the Innovation of Science and Technology of Fujian Province, China
  • Joint Fund for the Innovation of Science and Technology of Fujian Procince, China
  • 福建省科技厅 | Natural Science Foundation of Fujian Province

Zitieren

APA

Jiang, F., Dang, Y., Zhang, Z., Yan, Y., Wang, Y., Chen, Y., Chen, L., Zhang, J., Liu, J., & Wang, J. (2025). Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis. mSystems, 10(1). https://doi.org/10.1128/msystems.00765-24

Vancouver

Jiang F, Dang Y, Zhang Z, Yan Y, Wang Y, Chen Y, et al. Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis. mSystems. 2025;10(1). doi:10.1128/msystems.00765-24

BibTeX
@article{Jiang2025,
  author = {Jiang, Fengle and Dang, Yuan and Zhang, Zheting and Yan, Yanan and Wang, Yingchao and Chen, Yi and Chen, Lihong and Zhang, Jialiang and Liu, Jingfeng and Wang, Jianmin},
  title = {Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis},
  journal = {mSystems},
  year = {2025},
  volume = {10},
  number = {1},
  doi = {10.1128/msystems.00765-24}
}
Kostenlos starten →